BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Medium (6M)
Nirmal Bang Recommends 'Buy' On Cadila Healthcare
According to Nirmal Bang, Cadila Healthcare is expected to see a minor decline in earnings on a quarter-on-quarter basis, as Levorphanol has seen a full quarter of competition. A rebound in the domestic business, driven by completion of restructuring activities, should offset some of the pain for the company in the US, the brokerage adds.